
Journal of Nutrition, Journal Year: 2025, Volume and Issue: unknown
Published: Feb. 1, 2025
Language: Английский
Journal of Nutrition, Journal Year: 2025, Volume and Issue: unknown
Published: Feb. 1, 2025
Language: Английский
Journal of Extracellular Vesicles, Journal Year: 2024, Volume and Issue: 13(7)
Published: July 1, 2024
Abstract Gut microbiome dysbiosis is a major contributing factor to several pathological conditions. However, the mechanistic understanding of communication between gut microbiota and extra‐intestinal organs remains largely elusive. Extracellular vesicles (EVs), secreted by almost every form life, including bacteria, could play critical role in this inter‐kingdom crosstalk are focus present study. Here, we novel approach for isolating lipopolysaccharide (LPS)+ bacterial extracellular (bEV LPS ) from complex biological samples, faeces, plasma liver lean diet‐induced obese (DIO) mice. bEV were extensively characterised using nanoparticle tracking analyses, immunogold labelling coupled with transmission electron microscopy, flow cytometry, super‐resolution microscopy 16S sequencing. In tissues, protein expressions TLR4 few macrophage‐specific biomarkers assessed immunohistochemistry, gene inflammation‐related cytokines their receptors ( n = 89 genes) measured PCR array. Faecal samples DIO mice revealed remarkably lower concentration total EVs but significantly higher percentage LPS+ EVs. Interestingly, faecal showed abundance Proteobacteria Importantly, mice, number consistently entered hepatic portal vein subsequently reached liver, associated increased expression TLR4, macrophage markers (F4/80, CD86 CD206), Il1rn , Ccr1 Cxcl10 Il2rg Ccr2 ). Furthermore, portion escaped peripheral circulation. conclusion, be key mediator orchestrating various well‐established effects induced bacteria on distant organs.
Language: Английский
Citations
9Cancer Immunology Immunotherapy, Journal Year: 2024, Volume and Issue: 73(6)
Published: April 25, 2024
Abstract Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with a highly immunosuppressive microenvironment. This single-blind, randomized study aimed to evaluate the synergistic immunomodulatory effects of synbiotics (probiotics and inulin prebiotics), as well their impact on postoperative complications outcomes, compared use probiotics alone. Ninety patients diagnosed PDAC were enrolled randomly assigned into three groups: placebo group, group (receiving mixture ten strains Lactobacillus, Bifidobacterium, Streptococcus bacteria at dose 25 billion CFUs), (the same along prebiotics). The interventions administered for 14 days before surgery continued one month postoperatively. Tumor tissue infiltration CD8 + T cells expression IFN γ assessed by immunohistochemistry (IHC). Inflammatory cytokines concentrations, including Il 1 B, IL 6, 10, evaluated ELISA various time points pre- postoperative. Furthermore, followed up after assess short-term outcomes. Our results showed significant elevation cell proportion in ( p = 0.049, 0.013, respectively). gradual decrease probiotics-treated groups 0.000 both). Administration significantly decreased rate anastomotic leakage, diarrhea, abdominal distension 0.032, 0.044, 0.042, respectively), remarkable reduction bacteremia group. These revealed that this formulation potentially enhances immune response reduces associated surgery. Clinical trial identification : NCT06199752 (27-12-2023)
Language: Английский
Citations
8Food and Chemical Toxicology, Journal Year: 2024, Volume and Issue: 186, P. 114600 - 114600
Published: March 13, 2024
Language: Английский
Citations
8Cells, Journal Year: 2023, Volume and Issue: 12(6), P. 901 - 901
Published: March 15, 2023
Cigarette smoking (CS) or ambient particulate matter (PM) exposure is a risk factor for metabolic disorders, such as insulin resistance (IR), increased plasma triglycerides, hyperglycemia, and diabetes mellitus (DM); it can also cause gut microbiota dysbiosis. In smokers with CS cessation decreases the risks of serious pulmonary events, inflammation, disorder. This review included recent studies examining mechanisms underlying effects PM on dysbiosis disorder development; one potential disruption lung–gut axis, leading to dysbiosis, intestinal dysfunction, systemic disease. Short-chain fatty acids (SCFAs) are primary metabolites bacteria, which derived from fermentation dietary fibers. They activate G-protein-coupled receptor (GPCR) signaling, suppress histone deacetylase (HDAC) activity, inhibit facilitating maintenance health biofunction. The aforementioned reduces SCFA levels. Treatment targeting SCFA/GPCR signaling may alleviate air pollution–associated inflammation involve axis disruption.
Language: Английский
Citations
15International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 24(7), P. 6721 - 6721
Published: April 4, 2023
The use of probiotics has been considered as a new therapy option for ulcerative colitis (UC), and yeast recently received widespread recommendation human health. In this study, the probiotic characteristics four strains, Saccharomyces boulardii CNCMI-745, Kluyveromyces marxianus QHBYC4L2, cerevisiae QHNLD8L1, Debaryomyces hansenii QSCLS6L3, were evaluated in vitro; their ability to ameliorate dextran sulfate sodium (DSS)-induced was investigated. Among these, S. QHNLD8L1 protected against colitis, which reflected by increased body weight, colon length, histological injury relief, decreased gut inflammation markers, intestinal barrier restoration. abundance pathogenic bacteria Escherichia-Shigella Enterococcaceae mice with after treatment. Moreover, enriched beneficial Lactobacillus, Faecalibaculum, Butyricimonas, enhanced carbon metabolism fatty acid biosynthesis function, short chain (SCFAs) production. Taken together, our results indicate great potential supplementation prevention alleviation UC.
Language: Английский
Citations
13Current Microbiology, Journal Year: 2023, Volume and Issue: 81(1)
Published: Nov. 8, 2023
Language: Английский
Citations
13Antibiotics, Journal Year: 2022, Volume and Issue: 11(10), P. 1431 - 1431
Published: Oct. 18, 2022
Background: Tuberculosis (TB) is an infectious disease caused by the bacillus Mycobacterium tuberculosis (Mtb). TB treatment based on administration of three major antibiotics: isoniazid, rifampicin, and pyrazinamide. However, multi-drug resistant (MDR) Mtb strains are increasing around world, thus, allowing to spread world. The stringent response demonstrated in order survive under hostile circumstances, even including exposure antibiotics. mediated alarmones, which regulate bacterial replication, transcription translation. Moreover, cell wall contributes mechanism antibiotic resistance along with efflux pump activation biofilm formation. Immunity over course managed M1-macrophages M2-macrophages, immune against infection, former exerting inflammatory reactions latter promoting anti-inflammatory profile. T helper 1 cells via secretion interferon (IFN)-gamma, play a protective role TB, while regulatory secreting interleukin 10, anti-inflammatory. Alternative therapeutic options require further discussion. In view number MDR strains, attempts replace antibiotics natural biological products have been object intensive investigation. Therefore, this review anti-Mtb effects exerted probiotics, polyphenols, antimicrobial peptides IFN-gamma will be discussed. All above cited compounds endowed either direct antibacterial activity or immunomodulating characteristics.
Language: Английский
Citations
19Food Research International, Journal Year: 2024, Volume and Issue: 197, P. 115192 - 115192
Published: Oct. 25, 2024
Language: Английский
Citations
4Journal of Experimental Pharmacology, Journal Year: 2025, Volume and Issue: Volume 17, P. 1 - 14
Published: Jan. 1, 2025
Abstract: Acne vulgaris is a prevalent dermatological condition characterized by comedones, papules, and pustules, with significant physical psychological implications. Conventional treatments for this condition, including antibiotics retinoids, face challenges, such as side effects antibiotic resistance, necessitating alternative treatments. Recent studies show the potential of probiotics to modulate skin microbiome alleviate acne symptoms. Therefore, study aimed consolidate evidence from randomized controlled trials (RCTs) clinical investigations, evaluating efficacy in management. A comprehensive literature search was conducted across PubMed, Scopus, Cochrane databases using several keywords, "probiotic", "microbiome", "acne vulgaris". Inclusion criteria are RCTs 2009 2024 examining treatment. Studies were selected, screened, analyzed based on population, intervention, design, results. Descriptive statistics used summarize characteristics. Fifteen 811 participants met inclusion criteria. The tested various oral topical probiotics, Lactobacillus, Bifidobacterium, Bacillus , Enterococcus strains, over treatment periods ranging 4 12 weeks. results showed that reduced lesions, improved barrier function, decreased inflammatory markers. Both balancing reducing severity. Some reported outcomes comparable conventional treatments, benzoyl peroxide. However, there variability individual responses different probiotic effects, though rare, have been some cases. Probiotics presented natural, effective future needed determine optimal protocols. Keywords: microbiome, vulgaris, bacterial imbalance, conditions
Language: Английский
Citations
0Elsevier eBooks, Journal Year: 2025, Volume and Issue: unknown, P. 17 - 50
Published: Jan. 1, 2025
Language: Английский
Citations
0